- THIS ARTICLE
- Full Text
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Bilger, A.
- Articles by Drinkwater, N. R.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Bilger, A.
- Articles by Drinkwater, N. R.
Genetics, Vol. 167, 859-866, June 2004, Copyright © 2004
doi:10.1534/genetics.103.024521
A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1
Linkage Analysis and Characterization of Congenic Lines
Andrea Bilger, L. Michelle Bennett1, Reynaldo A. Carabeo2, Teresa A. Chiaverotti3, Cecily Dvorak4, Kristin M. Liss, Susan A. Schadewald, Henry C. Pitot and Norman R. Drinkwater5
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706
5 Corresponding author: McArdle Laboratory for Cancer Research, 1400 University Ave., University of Wisconsin Medical School, Madison, WI 53706.
E-mail: drinkwater{at}oncology.wisc.edu
The C3H/HeJ (C3H) and CBA/J (CBA) mouse strains are classical mouse models of cancer susceptibility, exhibiting high risks for both spontaneous and chemically induced liver cancer. By analysis of backcrosses and intercrosses between C3H or CBA and resistant B6 mice, we have mapped a potent modifier of hepatocellular carcinoma development to distal chromosome 1, linked to the marker D1Mit33 with combined LODW scores of 
5.9 (C3H) and 6.5 (CBA). We previously identified this region as one of two that modify susceptibility in the more distantly related C57BR/cdJ (BR) strain. Congenic B6.C3H(D1Mit5-D1Mit17) and B6.BR(D1Mit5-D1Mit17) mice developed significantly more liver tumors than B6 mice did (6- to 13-fold, P < 10–11, in males; 3- to 4-fold, P < 10–3, in females). Thus, distal chromosome 1 carries one or more genes that are sufficient to confer susceptibility to liver cancer.
This article has been cited by other articles:
 |
|
 |
|
  H. Wang, D. Teske, A. Tess, R. Kohlhepp, Y. Choi, C. Kendziorski, and A. R. Moser Identification of Novel Modifier Loci of ApcMin Affecting Mammary Tumor Development Cancer Res., December 1, 2007; 67(23): 11226 - 11233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. De Miglio, P. Virdis, D. F. Calvisi, M. Frau, M. R. Muroni, M. M. Simile, L. Daino, G. M. Careddu, E. Sanna-Passino, R. M. Pascale, et al. Mapping a Sex Hormone-Sensitive Gene Determining Female Resistance to Liver Carcinogenesis in a Congenic F344.BN-Hcs4 Rat Cancer Res., November 1, 2006; 66(21): 10384 - 10390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Thomae, E. A. Stevens, A. L. Liss, N. R. Drinkwater, and C. A. Bradfield The Teratogenic Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Modified by a Locus on Mouse Chromosome 3 Mol. Pharmacol., March 1, 2006; 69(3): 770 - 775. [Abstract] [Full Text] [PDF]
|
|